Eversept Partners, LP Shockwave Medical, Inc. Transaction History

Eversept Partners, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$191.17 - $325.63 $904,807 - $1.54 Million	4,733 Added 6.24%	80,555 $26.2 Million
Q4 2023 Feb 14, 2024	SELL	$160.99 - $215.69 $1.39 Million - $1.86 Million	-8,640 Reduced 10.23%	75,822 $14.4 Million
Q3 2023 Nov 14, 2023	BUY	$194.33 - $283.97 $12.5 Million - $18.3 Million	64,324 Added 319.42%	84,462 $16.8 Million
Q2 2023 Nov 08, 2023	SELL	$223.05 - $302.68 $6.12 Million - $8.31 Million	-27,439 Reduced 57.67%	20,138 $5.75 Million
Q2 2023 Aug 14, 2023	SELL	$223.05 - $302.68 $6.12 Million - $8.31 Million	-27,439 Reduced 57.67%	20,138 $5.75 Million
Q1 2023 Nov 08, 2023	BUY	$175.41 - $217.92 $7.77 Million - $9.65 Million	44,277 Added 1341.73%	47,577 $10.3 Million
Q1 2023 May 15, 2023	BUY	$175.41 - $217.92 $8.35 Million - $10.4 Million	47,577 New	47,577 $10.3 Million
Q2 2022 Nov 08, 2023	SELL	$115.91 - $214.48 $1.95 Million - $3.61 Million	-16,838 Reduced 83.61%	3,300 $630,000
Q2 2022 Aug 15, 2022	BUY	$115.91 - $214.48 $382,503 - $707,784	3,300 New	3,300 $631,000

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.